All compounds sold on this site are research-grade materials intended exclusively for in-vitro laboratory research by qualified professionals.
A triple-agonist research peptide targeting the GIP, GLP-1, and glucagon receptors, studied in metabolic and energy-expenditure models.
Published preclinical literature has examined RT-GLP’s effects on lipid metabolism, thermogenesis, and glucose regulation.
Identity
RT-GLP 15 mg · CAS 2381089-83-2
GIP / GLP-1 / glucagon triple agonist
≥99% HPLC · 3 mL vial
RT-GLP extends the incretin approach by adding glucagon-receptor agonism to the GIP/GLP-1 pair (a triple agonist). Published preclinical literature has examined its effects on energy expenditure, hepatic lipid handling, and glucose regulation.
Reconstitution & storage
Common research protocol — 2 mL bacteriostatic water yields a working solution for laboratory use. Lyophilised: store at 2–8 °C, protected from light; refer to the lot CoA for expiration. Reconstituted: refrigerate at 2–8 °C; long-term storage at −20 °C per laboratory protocol.
Documentation — batch Certificate of Analysis (HPLC, third-party) provided for the lot shipped.
For Research Use Only. Not for Human or Veterinary Use. Not a drug, food, or supplement; not evaluated by the FDA; not intended for human or animal use.
